FIGURE

Fig. 6

ID
ZDB-FIG-250528-6
Publication
Chen et al., 2025 - The combination of midkine inhibitor with Lenvatinib amplifies the suppression of hepatocellular carcinoma
Other Figures
All Figure Page
Back to All Figure Page
Fig. 6

The combination of iMDK and Lenvatinib inhibits the growth of subcutaneous tumors in a mouse model of HCC. (A) Overview diagram of animal experiments. (B) Physical representation of subcutaneous tumors in mice during sample collection. Tumor volumes were calculated using the formula (length × width2)/2. Compare the significance of the difference between each group and the blank group using Student's t-test. (C) Body weight changes in mice throughout the administration period, with day 0 marked as the day of administration. (D) Results of H&E staining and IHC with HCC. Quantification of positive areas with ImageJ 2 software. Probability values p < .05 denote statistical differences, with statistical significance marked by “*” for p < .05 and “**” for p < .01. Six individuals were included in each experimental group (n = 6). All these experiments were conducted three times in a double-blind manner, and the quantification results are presented as the mean ± SD.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ IUBMB Life